Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Characterization of inflammatory bowel disease with urinary metabolic profiling

Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD,Orchard TR

(2009), Am J Gastroenterol, 104(6), 1435-44

Optimizing conventional therapies for inflammatory bowel disease

Sparrow MP, Irving PM, Hanauer SB

(2009), Curr Gastroenterol Rep, 11(6), 496-503

Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial

Roberts SK, Weltman MD, Crawford DH, McCaughan GW, Sievert W, Cheng WS, Rawlinson W, Desmond PV, Marks PS, Yoshihara M, Rizkalla B, Depamphilis JK, Dore GJ; Chariot Study Group

(2009), Hepatology, 50(4), 1045-55

Feasibility of video capsule endoscopy in the management of children with peutz-jeghers syndrome: a blinded comparison with barium enterography for the detection of small bowel polyps

Postgate A, Hyer W, Phillips R, Gupta A, Burling D, Bartram C, Marshall M, Taylor S, Brown G, Schofield G, Bassett P, Spray C, Fitzpatrick A, Fraser C, Latchford A

(2009), J Pediatr Gastroenterol Nutr, 49(4), 417-23

Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection

Li S, Floess S, Hamann A, Gaudieri S, Lucas A, Hellard M, Roberts S, Paukovic G, Plebanski M, Loveland BE, Aitken C, Barry S, Schofield L, Gowans EJ

(2009), PLoS Pathog, 5(12), e1000707

Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease

Leung Y, Sparrow MP, Schwartz, M and Hanauer SB

(2009), J Crohns Colitis, 3(3), 162-67

Thiopurines, a previously unrecognized cause for fatigue in patients with inflammatory bowel disease

Lee TW, Iser J, Sparrow MP, Newnham ED, Headon BJ, Gibson PR

(2009), J Crohns Colitis, 3(3), 196-99

Minimally invasive prediction of esophageal varices and portal hypertension

Kemp W, Roberts S

(2009), J Gastroenterol Hepatol, 24(9), 1480-1

Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy

Gaudieri S, Rauch A, Pfafferott K, Barnes E, Cheng W, McCaughan G, Shackel N, Jeffrey GP, Mollison L, Baker R, Furrer H, Günthard HF, Freitas E, Humphreys I, Klenerman P, Mallal S, James I, Roberts S, Nolan D, Lucas M

(2009), Hepatology, 49(4), 1069-82

GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease

Berzsenyi M, Bowden DS, Roberts SK, Revill PA

(2009), J Gastroenterol Hepatol, 24(8), 1407-10

Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs

Sheffield LJ, Irving P, Gupta A, Byron K, Macrae FA, Phillimore H, Dronavalli M, Rose R, George P, Walmsley T, Dixon B, Poole S, Dooley M, Sparrow M

(2009), Pharmacogenomics, 10(7), 1091-9

Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C

Roberts SK, Cooksley G, Dore GJ, Robson R, Shaw D, Berns H, Hill G, Klumpp K, Najera I, Washington C

(2008), Hepatology, 48(2), 398-406

Urotensin II in chronic liver disease: in vivo effect on vascular tone.

Kemp W, Roberts S, Komesaroff PA, Zomer E, Krum H

(2008), Scand J Gastroenterol, 43(1), 103-9

Urotensin II in chronic liver disease: In vivo effect on vascular tone

Kemp W, Roberts S, Komesaroff PA, Zomer E, Krum H

(2007), Scand J Gastroenterol, 13, 1-7

Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis

Roberts S, Gordon A, McLean C, Pedersen J, Bowden S, Thomson K, Angus P

(2007), Clin Gastroenterol Hepatol, 5(8), 932-7

Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation

Roberts SK, Kemp W

(2007), J Gastroenterol Hepatol, 22(2), 191-6

Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection

Berzsenyi MD, Bowden DS, Kelly HA, Watson KM, Mijch AM, Hammond RA, Crowe SM, Roberts SK

(2007), Gastroenterology, 133(6), 1821-30

Therapeutic potential of blockade of the urotensin II system in systemic hypertension

Krum H, Kemp W

(2007), Curr Hypertens Rep, 9(1), 53-8

Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension

Kemp W, Krum H, Colman J, Bailey M, Yandle T, Richards M, Roberts S

(2007), Liver Int, 27(9), 1232-9

Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease

Kemp W, Pianko S, Nguyen S, Bailey MJ, Roberts SK

(2006), J Gastroenterol Hepatol, 21(8), 1355-6

24 25 26 27